par Bonneterre, J;Chevalier, B;Focan, Christian;Mauriac, L;Piccart-Gebhart, Martine 
Référence Annals of oncology, 12, 12, page (1683-1691)
Publication Publié, 2001-12
Référence Annals of oncology, 12, 12, page (1683-1691)
Publication Publié, 2001-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Bonneterre, J; Chevalier, B; Focan, Christian; Mauriac, L; Piccart-Gebhart, Martine |
| Informations sur la publication: | Annals of oncology, 12, 12, page (1683-1691) |
| Statut de publication: | Publié, 2001-12 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| MeSH keywords: | Administration, Oral |
| Adult | |
| Aged | |
| Antineoplastic Agents, Phytogenic -- administration & dosage | |
| Antineoplastic Agents, Phytogenic -- pharmacokinetics | |
| Area Under Curve | |
| Breast Neoplasms -- drug therapy | |
| Breast Neoplasms -- metabolism | |
| Dose-Response Relationship, Drug | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Intestinal Absorption | |
| Maximum Tolerated Dose | |
| Middle Aged | |
| Neoplasm Staging | |
| Neutropenia -- chemically induced | |
| Safety | |
| Treatment Outcome | |
| Vinblastine -- administration & dosage | |
| Vinblastine -- analogs & derivatives | |
| Vinblastine -- pharmacokinetics | |
| Note générale: | Clinical Trial |
| Clinical Trial, Phase I | |
| Journal Article | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0923-7534 |
| info:doi/10.1023/A:1013529731138 | |
| info:scp/0035702333 | |
| info:pmid/11843245 |
